Multiple endocrine neoplasia type 1 About a case

Authors

  • Roberto Barreno Universidad Central del Ecuador, Hospital Eugenio Espejo
  • Verónica Ayala Universidad Central del Ecuador, Hospital Eugenio Espejo
  • Isabel Guamán Universidad Central del Ecuador, Hospital Eugenio Espejo
  • Nestor Basantes Universidad Central del Ecuador, Hospital Eugenio Espejo
  • Edgar Changoluisa Universidad Central del Ecuador, Hospital Eugenio Espejo
  • Margarita del Rocío Montes Moreno Escuela Superior Politécnica de Chimborazo

Keywords:

multiple endocrine neoplasia, NEM1, Zollinger Ellison syndrome, adenohypophysis, pancreatic islets, parathyroid

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant hereditary syndrome, classically characterized by the presence of tumors in several glands (parathyroid, anterior pituitary and pancreatic islets)12

The prevalence of MEN 1 is approximately 2 per 100,000 inhabitants.11

The Zollinger Ellison syndrome (ZES) is one of the three neoplasias that form part of the MEN 1, and corresponds to 20 to 60%.1

The clinical case of a 66-year-old male patient, with a clinical of Zollinger Ellison Syndrome, who in a subsequent investigation shows functional abnormality of the parathyroid glands, fulfilling diagnostic criteria of Multiple Endocrine Neoplasia type 1 (NEM1)

Downloads

Download data is not yet available.

Author Biographies

  • Roberto Barreno, Universidad Central del Ecuador, Hospital Eugenio Espejo

    Médico Internista, Subespecialidad de Gastroenterología, Quito, Ecuador

  • Verónica Ayala, Universidad Central del Ecuador, Hospital Eugenio Espejo

    Médico Internista, Subespecialidad de Gastroenterología, Quito, Ecuador

  • Isabel Guamán, Universidad Central del Ecuador, Hospital Eugenio Espejo

    Médico Internista, Subespecialidad de Gastroenterología, Quito, Ecuador

  • Nestor Basantes, Universidad Central del Ecuador, Hospital Eugenio Espejo

    Médico Internista, Subespecialidad de Gastroenterología, Quito, Ecuador

  • Edgar Changoluisa, Universidad Central del Ecuador, Hospital Eugenio Espejo

    Médico Internista, Subespecialidad de Gastroenterología,  Quito, Ecuador

  • Margarita del Rocío Montes Moreno, Escuela Superior Politécnica de Chimborazo

    Medicina General, Quito, Ecuador

References

Zollinger R EE. Primary Peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Annals of Surgery. 1955 October;pp.1-10.

Anlauf M GNea. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: Distintc clinico-pathological and epidemiological features. World J Gastroenterology. 2006 September; 14.

Sanabria C PFN. Gastrinoma. Endocrinol Nutr. 2007;54(1):21-30.

Plockinger U RG. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. Neuroendocrinology. 2005 April.

Sinagra E PG. An unusual presentation of Zollinger Ellison Syndrome. Gastroenterology. 2013.

Donow C PM. Surgical Pathology of Gastrinoma. Cancer. 1991 September 15.

Pipeleers M SGWGFA. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and Zollinger-Ellison Syndrome. New England Journal of Medicine. 1990 March; 322(11): p. 723-727.

Settara C. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science. 1997 April 18.

Manjunath G TBARea. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India. Familial Cancer. 2016 Febrary 23;: pp. 1-8.

Yuan Z CCSMea. Loss of MEN 1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN 1 tumorigenesis. Oncotarget. 2016;7(11):12633-12650.

Thakker R NPWGea. Clinical practice guideline for multiple endocrine neoplasia type 1 (MEN 1). J Clin Endocrinol Metab. 2012; 97(9): p. 2990.

Brandi M GRAAea. Guidelines for diagnosis and therapy of MEN typo 1 and type 2. J Clin Endocrinol Metab. 2001; 86(12): p. 5658.

Bergsland E ea. Zollinger Ellison syndrome (gastrinoma): Clinical manifestations and diagnosis. Uptodate. 2016 Aug.

Deveney C DKea. Zollinger Ellison syndrome (gastrinoma) Current diagnosis and treatmente. Surg Clin North Am 1987;67(2):411

Meko J NJea. Management of patients with Zollinger Ellison. Annu Rev Med 1995;46:395.

Roy P VDSHea. Zollinger Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore). 2000;79(6):379.

Berna M HKGFea. Serum gastrin in Zollinger Ellison: I. Prospetive study of fasting serum gastrin in 309 patients from the national institutes of Health and comparison with 2229 cases from the literature. Medicine (Baltimore). 2006;85(6):295.

Nobels F KDCWea. Chromogranina A as serum maker for neuroendocrine neoplasia: comparison with neuron specific enolase and alpha subunit of glycoprotein hormones. J Clin Endocrinol Metab. 1997;82(8):2622.

Chandrasekharappa S GSMPea. Positional cloning of the gene for multiple endocrine neopasia type 1. Science. 1997;276(5311):404.

Akertrom G SPHPea. Surgical management of pancreatico duodenal tumors in multiple endocrine neoplasia syndrome type 1. Clinics. 2012;67(S1):173- 178.

Skogseig B RJAGea. Pancreatic endocrine tumors in multiple endocrine neoplasia type 1. Surgical Endocrinology. 2001;511-524.

López C WJFVea. Longterm results of surgery for pancreatic neuroendocrine neoplasia in patients with MEN 1. Langenbecks Arch Surg. 2011; 396(8):1187-1189.

Published

2016-12-01

Issue

Section

Clinical case

How to Cite

Similar Articles

1-10 of 457

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)